Samalin Investment Counsel’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $734K | Buy |
30,274
+657
| +2% | +$15.9K | 0.28% | 103 |
|
|
2025
Q1 | $751K | Buy |
29,617
+4,199
| +17% | +$106K | 0.3% | 97 |
|
|
2024
Q4 | $674K | Buy |
25,418
+605
| +2% | +$16.1K | 0.29% | 102 |
|
|
2024
Q3 | $718K | Buy |
24,813
+4,531
| +22% | +$131K | 0.31% | 94 |
|
|
2024
Q2 | $568K | Buy |
20,282
+1,025
| +5% | +$28.7K | 0.27% | 121 |
|
|
2024
Q1 | $534K | Buy |
19,257
+584
| +3% | +$16.2K | 0.25% | 127 |
|
|
2023
Q4 | $538K | Buy |
18,673
+7,361
| +65% | +$212K | 0.27% | 117 |
|
|
2023
Q3 | $375K | Buy |
11,312
+862
| +8% | +$28.6K | 0.22% | 143 |
|
|
2023
Q2 | $383K | Buy |
10,450
+37
| +0.4% | +$1.36K | 0.21% | 138 |
|
|
2023
Q1 | $425K | Sell |
10,413
-713
| -6% | -$29.1K | 0.26% | 116 |
|
|
2022
Q4 | $570K | Sell |
11,126
-546
| -5% | -$28K | 0.36% | 83 |
|
|
2022
Q3 | $511K | Buy |
11,672
+791
| +7% | +$34.6K | 0.37% | 78 |
|
|
2022
Q2 | $571K | Buy |
10,881
+33
| +0.3% | +$1.73K | 0.4% | 67 |
|
|
2022
Q1 | $562K | Sell |
10,848
-477
| -4% | -$24.7K | 0.34% | 82 |
|
|
2021
Q4 | $669K | Buy |
11,325
+339
| +3% | +$20K | 0.4% | 67 |
|
|
2021
Q3 | $472K | Buy |
10,986
+385
| +4% | +$16.5K | 0.31% | 102 |
|
|
2021
Q2 | $415K | Buy |
10,601
+43
| +0.4% | +$1.68K | 0.27% | 122 |
|
|
2021
Q1 | $382K | Buy |
10,558
+426
| +4% | +$15.4K | 0.26% | 123 |
|
|
2020
Q4 | $373K | Sell |
10,132
-22
| -0.2% | -$810 | 0.28% | 116 |
|
|
2020
Q3 | $354K | Buy |
10,154
+40
| +0.4% | +$1.4K | 0.32% | 103 |
|
|
2020
Q2 | $313K | Buy |
10,114
+2,360
| +30% | +$73K | 0.33% | 100 |
|
|
2020
Q1 | $240K | Sell |
7,754
-10
| -0.1% | -$310 | 0.32% | 97 |
|
|
2019
Q4 | $288K | Buy |
+7,764
| New | +$288K | 0.24% | 115 |
|